Researchers Uncover New Pathways in Diabetes Research

A new Florida State University study is changing how scientists look at diabetes research and the drugs used to treat the disease.

In the Proceedings of the National Academy of Sciences, Associate Professor of Chemistry Brian Miller and post-doctoral researcher Carl Whittington report that a key enzyme involved in the body’s response to glucose can essentially be corrupted by a new mechanism that scientists have not seen before. This discovery shifts the current understanding of how this enzyme participates in certain diseases, including hyperinsulinemia and diabetes.